High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone–Suppressive Therapy for Thyroid Carcinoma
暂无分享,去创建一个
M. Memo | A. Formenti | G. Banfi | G. Mazziotti | R. Maroldi | A. Giustina | R. Giubbini | S. Frara | R. Olivetti
[1] Kehu Yang,et al. The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies , 2018, Journal of Bone and Mineral Metabolism.
[2] Masato Tanaka,et al. Discrimination between Malignant and Benign Vertebral Fractures Using Magnetic Resonance Imaging , 2017, Asian spine journal.
[3] S. Asa. The evolution of differentiated thyroid cancer. , 2017, Pathology.
[4] A. Formenti,et al. Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study. , 2017, Bone.
[5] J. Bilezikian,et al. Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines , 2016, Endocrine.
[6] T. Oh,et al. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma , 2016, The Journal of clinical endocrinology and metabolism.
[7] G. Mazziotti,et al. Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency , 2016, Endocrine.
[8] A. Uitterlinden,et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. , 2015, JAMA.
[9] L. Hegedüs,et al. The Excess Risk of Major Osteoporotic Fractures in Hypothyroidism Is Driven by Cumulative Hyperthyroid as Opposed to Hypothyroid Time: An Observational Register‐Based Time‐Resolved Cohort Analysis , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] GanlyIan,et al. Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma , 2015 .
[11] J. Christodoulou,et al. Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression , 2015, Clinical endocrinology.
[12] I. Floriani,et al. Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. , 2015, The Journal of clinical endocrinology and metabolism.
[13] L. Hegedüs,et al. Low Serum Thyrotropin Level and Duration of Suppression as a Predictor of Major Osteoporotic Fractures—The OPENTHYRO Register Cohort , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] D. Bauer,et al. Subclinical Thyroid Dysfunction and the Risk for Fractures , 2014, Annals of Internal Medicine.
[15] G. Williams. Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine? , 2014, Journal of Endocrinological Investigation.
[16] A. Bianchi,et al. Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism. , 2014, European journal of endocrinology.
[17] L. Hegedüs,et al. Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures - the openthyro register cohort , 2014 .
[18] A. Avenell,et al. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. , 2014, The Cochrane database of systematic reviews.
[19] Ju-Young Kim,et al. Levothyroxine Dose and Fracture Risk According to the Osteoporosis Status in Elderly Women , 2014, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[20] J. Shepherd,et al. Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on Body Composition. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[21] A. Bianchi,et al. Vertebral fractures in patients with acromegaly: a 3-year prospective study. , 2013, The Journal of clinical endocrinology and metabolism.
[22] P. Cawthon,et al. A prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] T. Yuen,et al. Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. , 2012, The Journal of clinical investigation.
[24] H. Genant,et al. New advances in imaging osteoporosis and its complications , 2012, Endocrine.
[25] D. Cocchi,et al. New understanding and treatments for osteoporosis , 2012, Endocrine.
[26] E. Menis,et al. High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas , 2011, Pituitary.
[27] J. Cauley,et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. , 2010, Archives of internal medicine.
[28] G. Mazziotti,et al. Drug-induced osteoporosis: mechanisms and clinical implications. , 2010, The American journal of medicine.
[29] G. Mazziotti,et al. Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. , 2010, Bone.
[30] B. Biondi,et al. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. , 2010, Thyroid : official journal of the American Thyroid Association.
[31] Stephanie L. Lee,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[32] S. Mandel,et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[33] G. Mazziotti,et al. Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. , 2009, Bone.
[34] G. Lupoli,et al. Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate. , 2009, Thyroid : official journal of the American Thyroid Association.
[35] J. Bassett,et al. Critical role of the hypothalamic-pituitary-thyroid axis in bone. , 2008, Bone.
[36] G. Brabant,et al. Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets? , 2008, The Journal of clinical endocrinology and metabolism.
[37] S. Vukicevic,et al. Thyroid‐Stimulating Hormone Restores Bone Volume, Microarchitecture, and Strength in Aged Ovariectomized Rats* , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] M. Mussap,et al. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study. , 2007, Metabolism: clinical and experimental.
[39] S. Giannini,et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. , 2006, Bone.
[40] A. Bianchi,et al. Increased Prevalence of Radiological Spinal Deformities in Adult Patients With GH Deficiency: Influence of GH Replacement Therapy , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] R. Lindsay,et al. Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis , 2005, Osteoporosis International.
[42] B. Biondi,et al. Recombinant Human TSH Modulates In Vivo C‐Telopeptides of Type‐1 Collagen and Bone Alkaline Phosphatase, but Not Osteoprotegerin Production in Postmenopausal Women Monitored for Differentiated Thyroid Carcinoma , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] E. Murphy,et al. The thyroid and the skeleton , 2004, Clinical endocrinology.
[44] M. Zaidi,et al. TSH Is a Negative Regulator of Skeletal Remodeling , 2003, Cell.
[45] J. Kanis,et al. Association Between Vertebral Fracture and Increased Mortality in Osteoporotic Patients , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] P. Vestergaard,et al. Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. , 2003, Thyroid : official journal of the American Thyroid Association.
[47] D. Bauer,et al. Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone , 2001, Annals of Internal Medicine.
[48] F. Greenspan,et al. The Effect of Thyroid Hormone on Skeletal Integrity , 1999, Annals of Internal Medicine.
[49] S. Cummings,et al. The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study , 1998, Annals of Internal Medicine.
[50] F. Di Stefano,et al. Use of disphosphonates in the treatment of osteoporosis in thyroidectomized patients on levothyroxin replacement therapy. , 1997, Archives of gerontology and geriatrics.
[51] M. Nevitt,et al. Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[52] C. Cooper,et al. Incidence of clinically diagnosed vertebral fractures: A population‐based study in rochester, minnesota, 1985‐1989 , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[53] E. Castanas,et al. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. , 1980, The Journal of clinical endocrinology and metabolism.
[54] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[55] Kaliszewski,et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .
[56] J. Li,et al. Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies , 2015, Osteoporosis International.
[57] J. Kanis,et al. Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures , 2013, Osteoporosis International.
[58] J. Shepherd,et al. Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[59] A. Morris,et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. , 2010, The Journal of clinical endocrinology and metabolism.
[60] D. Bauer,et al. Thyroid Studies Collaboration , 2010 .